- Entry
- $16.31
- Now
- $15.90 -2.5%
- Target
- —
- Score
- —
Guys, I think I just noticed a textbook case of reflexivity - PSNL, Personalis. This tiny and very little known company powers the engine behind the recently hyped Merck-Moderna cancer vaccine. Despite the huge revenue upside from the vaccine, the stock has barely performed after the news, due to its previous merger agreement with Tempus at $16.25, which was BEFORE the vaccine update and is still pending shareholders’ vote. This is where things get interesting- after the vaccine news, PSNL …
— ORIGINAL POST ·
PSNL - a textbook case of reflexivity from Soros’ Alchemy of Finance?
· r/stocks
· Aug 28, 2026